Social reactions to Valium and Prozac: A cultural lag perspective of drug diffusion and adoption

Research in Social and Administrative Pharmacy

Volumn 5, Issue 2, 2009, Pages 94-107

  Marshall, Kimball P ^a   Georgievskava, Zhanna ^a   Georgievsky, Igor ^a  

^a ALCORN STATE UNIVERSITY   (United States)

Author keywords

Cultural lag; Drug diffusion; Prozac; Technology commercialization; Valium

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; DIAZEPAM; FLUOXETINE;

CULTURAL ANTHROPOLOGY; DRUG INDUSTRY; HISTORY; HUMAN; MARKETING; METHODOLOGY; PUBLIC OPINION; REVIEW; SOCIAL ENVIRONMENT;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHLORDIAZEPOXIDE; CULTURE; DIAZEPAM; DRUG INDUSTRY; FLUOXETINE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MARKETING; PUBLIC OPINION; SOCIAL ENVIRONMENT;

EID: 67349212262     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2008.06.005     Document Type: Review

References (118)

1. Ogburn W.F. Social Change (1922), B.W. Huebsch, Inc, New York, NY
2. Stolley P. Cultural lag in health care. Inquiry 8 (1971) 71-76
3. Garattini S. The drug market in four European countries. Pharmacoeconomics 14 (1998) 69-79
4. Studdert D.M., Mello M.M., and Brennan T.A. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-self-regulation in the shadow of federal prosecution. N Engl J Med 351 (2004) 1891-2000
5. Mello M.M., Rosenthal M., and Neumann P.J. Direct to consumer advertising and shared liability for pharmaceutical manufacturers. JAMA 289 (2003) 477-481
6. Smith M.C. A Social History of the Minor Tranquilizers (1991), Pharmaceutical Products Press, Binghamton, NY
7. Rickels K. Research Analysis and Utilization System (1980), Conference National Institute of Drug Abuse, Washington, DC
8. Evan W.M. Voting technology, political institutions, legal institutions and civil society: a study of the hypothesis of cultural lag in reverse. Hist Technol 20 (2004) 165-184
9. Tilman R. Emile Durkheim and Thorstein Veblen on epistemology, cultural lag and social order. Hist Human Sci 15 (2002) 51-70
10. Simmons R.G., and DiCanio M. Biology, technology and health. In: Freedman H.E., Levin S., and Reeder G.G. (Eds). Handbook of Medical Sociology (1979), Prentice-Hall, Englewood Cliffs, NJ 150-173
11. Ogburn W.F. Social Change with Respect to Cultural and Original Nature (1966), Dell, New York, NY
12. Rogers E.M. Diffusion of Innovations (1962), The Free Press, New York, NY
13. Moynihan R., Heath I., and Henry D. Selling sickness: the pharmaceutical industry and disease mongering. Br Med J 324 (2002) 886-890
14. Calfee J.D. The role of marketing in pharmaceutical research and development. Pharmacoeconomics 3 (2002) 77-85
15. Wolfe S.M. Direct to consumer advertising-education or emotion. N Engl J Med 346 (2002) 524-526
16. Rosenthal M.B., Berndt E.R., Donohue J.M., Frank R.G., and Epstein A. Promotion of prescription drugs to consumers. N Engl J Med 346 (2002) 498-507
17. Allaway A.W. New product diffusion models book review. J Mark Res 38 (2001) 516-518
18. Talukdar D., Sudhir K., and Ainslie A. Investigating new product diffusion across products and countries. Mark Sci 21 (2002) 97-114
19. Mahajan V., Muller E., and Wind Y. New Product Diffusion Models (2000), Kluwer, Boston, MA
20. Manning K.C., Bearden W.O., and Madden T.J. Consumer innovativeness and the adoption process. J Consum Psychol 4 (1995) 329-345
21. Im S., Bayus B.L., and Mason C.H. An empirical study of innate consumer innovativeness, persona characteristics, and new-product adoption behavior. J Acad Mark Sci 31 (2003) 61-73
22. Dybdahl T., Andersen M., Sondergaard J., Kragstrup J., and Kristiansen I. Does the early adopter of drugs exist? A population-based study of general practitioners' prescribing of new drugs. Eur J Clin Pharmacol 60 (2004) 667-672
23. Van den Bulte C., and Stremersch S. Social contagion and income heterogeneity in new product diffusion: a meta-analytic test. Mark Sci 23 (2004) 530-544
24. Hollister L.E. Psychopharmacology in its second generation. Mil Med 141 (1976) 371-375
25. Shearer L. The man who invented Valium. Parade 8 (1976) 11-13
26. Blackwell B. Psychotropic drugs in use today: the role of diazepam in medical practice. JAMA 225 (1973) 1637-1641
27. Radelet ML. Social factors influencing medicalization of anxiety: a study of tranquilizer use [Ph.D. Dissertation]. Lafayette: Purdue University, 1977.
28. Radelet M.L. Medical Hegemony as Social Control: The Use of Tranquilizers (1977), Annual Meetings of the Society for the Study of Social Problems, Chicago, IL
29. Pekkanen J. The American Connection (1973), Folletts, Chicago, IL
30. Nelson G. Advertising and the national health. J Drug Issues 6 (1976) 28-33
31. Coleman J., Katz E., and Mendel H. Medical Innovation: A Diffusion Study (1966), Bobbs-Merrill, Indianapolis, IN
32. Reinstein P. A regulator's perception of drug advertising. J Drug Issues 6 (1976) 60-64
33. Hemminki E. Review of literature on factors affecting drug prescribing. Soc Sci Med 9 (1975) 111-115
34. Rock N.L., and Silsby H.D. The attitudes of American physicians stationed with the United States army, Europe, in regard to alcohol and drug abuse. Mil Med 140 (1975) 781-783
35. Raft D., Davidson J., Toomey T.C., Spencer R.F., and Lewis B.F. Inpatient and outpatient patterns of psychotropic drug prescribing by nonpsychiatrist physicians. Am J Psychiatry 132 (1975) 1309-1312
36. Davidson J.R.T., Raft D., Lewis F.B., and Gebhardt F. Psychotropic drugs on general medical and surgical wards of a teaching hospital. Arch Gen Psychiatry 32 (1975) 507-511
37. Whitehead W.E., Blackwell B., and Robinson A. Why physicians prescribe benzodiazepines in essential hypertension: a phase IV study. Biol Psychiatry 12 (1977) 597-601
38. Chambers C.D., Iniardi J.A., and Siegal H.A. Chemical Coping: A Report on Legal Drug Use in the United States (1975), Spectrum Publications, New York, NY
39. Baiter M.B. An Analysis of Psychotherapeutic Drug Consumption in the United States (1973), Royal Society of Medicine Anglo-American Conference on Drug Abuse, London, England
40. Linn L.S. Physician characteristics and attitudes toward legitimate use of psychotherapeutic drugs. J Health Soc Behav 12 (1971) 134
41. Parry J.J., Baiter M.B., Mel linger G.D., Cisin I.H., and Manheimer D.I. National patterns of psychotherapeutic drug use. Arch Gen Psychiatry 28 (1973) 769-783
42. Baiter M.B., Levine J., and Manheimer D.I. Cross-national study of the extent of anti-anxiety/sedative drug use. N Engl J Med 290 (1974) 769-774
43. Uhlenhuth E.H., Lipman R.S., Baiter M.B., and Stern M. Symptom intensity and life stress in the city. Arch Gen Psychiatry 31 (1974) 759-764
44. Uhlenhuth E.H., Baiter M.B., and Lipman R.S. Minor tranquilizers: clinical correlates of use in an urban population. Arch Gen Psychiatry 35 (1978) 650-655
45. Greenblatt D.J., Shader R.I., and Koch-Weser J. Psychotropic drug use in the Boston area: a report from the Boston Collaborative Drug Surveillance Program. Arch Gen Psychiatry 32 (1975) 518-521
46. Roth M., Gurney C., Garside R.F., and Kerr T.A. Studies in the classification of affective disorders: the relationship between anxiety states and depressive illness. Br J Psychiatry 121 (1972) 147
47. Blackwell B. Minor tranquilizers: use, misuse or overuse?. Psychosomatics 16 (1975) 28-31
48. Physicians' Desk Reference. 33rd ed. (1979), Medical Economics Co, Oradell, NJ
49. Hollister L.E. Drugs for emotional disorders. JAMA 234 (1975) 942-947
50. Popoff L.M. A simple method for diagnosis of depression by the family physician. Clin Med 76 (1969) 24-29
51. Greenblatt D.J., and Shader R.I. Benzodiazepines in Clinical Practice (1973), Raven Press, New York, NY
52. Fabrega H. The position of psychiatry in the understanding of human disease. Arch Gen Psychiatry 32 (1975) 1501-1512
53. Byck R. Drugs and treatment of psychiatric disorders. In: Goodman L.S., and Gilman A. (Eds). The Pharmacological Basis of Therapeutics (1975), Macmillan Publishing Co, New York, NY 152-200
54. Freedman H.E., Levine S., and Reeder L.G. Handbook of Medical Sociology. 3rd ed. (1979), Prentice Hall, Inc, Englewood Cliffs, NJ
55. Srole L., Langner T.S., Michael S.T., Opler M.D., and Rennie T.A.C. Mental Health in the Metropolis (1962), McGraw-Hill, New York, NY
56. Srole L. Measuremental classification in socio-psychiatric epidemiology: midtown Manhattan study (1954) and Midtown Manhattan restudy (1974). J Health Soc Behav 16 (1975) 347-364
57. Langner T.S., and Michael S.T. Life Stress and Mental Health (1963), Collier-Macmillan, London, England
58. Manning P.K., and Zucker M. The Sociology of Mental Health and Illness (1976), Bobbs-Merrill, Indianapolis, IN
59. Weissman M.M., and Klerman G.L. Epidemiology trends in the United States. Arch Gen Psychiatry 35 (1978) 705-712
60. Regier, Darrel A., Irving D. Goldberg and Carl A. Taube (1978), "The de facto U. S. mental health services system: A public health perspective," Archives of General Psychiatry, 35:685-693.
61. Gurin G., Veroff J., and Feld S. Americans View Their Mental Health (1960), Basic Books, New York, NY
62. Weissman M.M., Myers J.K., and Harding P.S. Psychiatric Disorders in a United States Urban Community: 1975-1976 (1977), Annual Meeting of the American Psychiatric Association, Toronto, Canada
63. Regier D.A., Goldberg I.D., and Taube C.A. The de facto U.S. mental health services system: a public health perspective. Arch Gen Psychiatry 35 (1978) 685-693
64. Ilfeld F.W. Psychologic status of community residents along major demographic dimensions. Arch Gen Psychiatry 35 (1978) 716-724
65. Steinfels P. Confronting the other drug problem. Hastings Cent Rep 11 (1972) 4-6
66. Trethowan W.H. Pills for personal problems. Br Med J 27 (1975) 749-751
67. Woody G.E., O'Brien C.P., and Greenstein R. Misuse and abuse of diazepam: an increasingly common medical problem. Int J Addict 165 (1975) 843-848
68. Keeler M.H., and McCurdy R.L. Medical practice without anti-anxiety drugs. Am J Psychiatry 132 (1975) 654-655
69. Safra M.J., and Oakley Jr. G.P. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 11 (1975) 478-480
70. Winstead D.K., Anderson A., Eilers M.K., Blackwell B., and Zaremba A.L. Diazepam on demand: drug-seeking behavior in psychiatric inpatients. Arch Gen Psychiatry 30 (1974) 349-351
71. Freid A. Prescribing of tranquilizers and barbiturates by general practitioners. Br Med J 2 (1976) 1232-1233
72. Greenblatt D.J., and Shader R.I. The clinical choice of sedative-hypnotics. Ann Intern Med 72 (1972) 91-100
73. Greenblatt D.J., Shader R.I., and Lofgren S. Rational psychopharmacology for patients with medical diseases. In: Creger W.P., Coggins C.H., and Hancock E.W. (Eds). Annual Review of Medicine: Selected Topics in the Clinical Sciences (1976), Annual Reviews, Palo Alto, CA
74. Hollister L.E. Valium: A discussion of current issues.: proceedings of a roundtable discussion on diazepam (Valium) held in Chicago May 20, 1976. Psychosomatics 18 (1977) 44-58
75. Burger A. History in Psychotherapeutic Drugs, Part 1-Principles (1976), Marcel Dekker, New York, NY 11-57
76. Klerman G.L. Psychotropic drugs as therapeutic agents. Hastings Cent Stud 2 (1974) 81-93
77. MD's warned on dangers of benzodiazepines. The Journal 12 (1968) 15
78. Mannheimer D.I., Davidson S.T., Baiter M.B., Mel linger G.D., Gisin I.H., and Parry H. Popular attitudes and beliefs about tranquilizers. Am J Psychiatry 130 (1973) 1246-1253
79. Moore M.S. Some myths about mental illness. Arch Gen Psychiatry 32 (1975) 1483-1497
80. Cant G. Valiumania. N. Y. Times Mag 2 (1976) 34-44
81. Danger ahead! Valium: the pill you love can turn on you. Vogue 165 (1975) 152-153
82. Tightening the lid on legal drugs. Sci News 107 (1975) 382
83. Berg R.H. The over-medicated women. McCall's 67 (1971) 109-111
84. Chambers C., and Schultz S. Women and drugs: the drugs women use. Ladies Home J 88 (1971) 130-131 191-192;194
85. Chambers C., and Schultz S. Women and drugs: housewives and the drug habit. Ladies Home J 88 (1971) 66-67 69-70;130
86. Chambers C., and Schultz S. Women and drugs: working women and drugs. Ladies Home J 89 (1972) 60 62;64;119
87. McMillan P. Women and tranquilizers. Ladies Home J 93 (1976) 164-167
88. Larned D. Do you take Valium?. Ms. Magazine 4 (1975) 26-29
89. Physicians' Desk Reference. 60th ed. (2006), Thompson, New York, NY 1771-1779
90. Milane M.S., Suchard M.A., Wong M.L., and Licinio J. Modeling of the temporal patterns of Fluoxetine prescriptions and suicide rates in the United States. PLoS Med 2 (2006) 0816-0824
91. Weissman M.M., Bland R.C., Canino G.J., et al. Cross-national epidemiology of major depressive and bipolar disorder. JAMA 276 (1996) 293-299
92. Wong M.L., and Licinio J. Biology of Depression: From Novel Insights to Therapeutic Strategies (2005), Wiley-VCH, Weinheim, Germany
93. Wu L.T. The estimated rate of depressed mood in U.S. adults: recent evidence for a peak in later life. J Affect Disord 60 (2000) 159-171
94. Moller HJ. Suicide, suicidality and suicide prevention in effective disorders. Acta Psychiatry Scand-Supplement. 2003;73-80.
95. Isacsson G., Holmgren P., Druid H., and Bergman U. Psychotropics and suicide prevention: implications from toxicological screening of 5281 suicides in Sweden 1992-1994. Br J Psychiatry 174 (1999) 259-265
96. Mycek M, Harvey R, Champe P. Pharmacology 1997;2nd Edition:119-125.
97. The promise of Prozac. Newsweek. 1990;Mar 26:38.
98. Breggin P.R. Talking Back to Prozac (1995), St. Martin Press, New York, NY
99. Healy D. Let Them Eat Prozac (2004), New York University Press, Albany, NY
100. Lilly sees improved financial outlook for the quarter of $1.26 to $1.32 earnings per share from continuing operations. Bus Wire. 1995;Mar 27.
101. Talking up Prozac. Milwaukee J Sentinel. 1997;Jul 1.
102. Wartik N. Prozac: the Verdict is. Am Health. 1996;Nov:58-61.
103. Toufexis A. Warnings about a miracle drug. Time 136 (1990) 54
104. Toufexis A. The personality pill. Time. 1993;Oct 11:62-63.
105. Galewitz P. Prozac's reign as top antidepressant ending. Assoc Press. 2000;Mar 7.
106. Drugs Most Frequently Prescribed in Physicians Offices, 1997. World Almanac and Book of Facts (2000), World Almanac Education Group, New York, NY 901
107. Alleged missing Prozac papers found, report suggests Lilly knew of risk. Chic Tribune Assoc Press. 2005;Jan 1.
108. The Rise of Senseless Violence in Society: Psychiatry's Role in the Creation of Crime (1992), Citizens Commission on Human Rights, Los Angeles, CA
109. Stein L. Kids and meds. U.S. News World Rep 137 (2004) 20
110. Japsen B. Do these drugs need a warning? Chic Tribune. 2005;Jun 09.
111. Japsen B. Track results of drug warning, AMA to ask. Chic Tribune. 2005;Jun 22.
112. Aschenbrenner D.S. The use of antidepressants in children and adolescents. Am J Nurs 105 (2005) 79-81
113. Thomas D. The PMS drug can help reduce symptoms, Omaha Nebraska doctors say. Omaha World Herald. 2001;Apr 3.
114. Gorman C. Prozac's worst enemy. Time. 1994;Oct 10:64-65.
115. Cowley G. The culture of Prozac. Newsweek. 1994;Feb 7:41-42.
116. Kramer P. Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self (1993), Penguin Books, New York, NY
117. Goleman D. Who's mentally ill?. Psychol Today 11 (1978) 34-41
118. Weisberger A.M. The ethics of broader usage of Prozac: social choice or social bias. Int J Appl Philos 10 (1995) 69-74